– Astellas contributed to the development of a pediatric formulation to treat schistosomiasis as a member of the Pediatric Praziquantel Consortium – TOKYO, Dec. 17, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) contributed to the development of a pediatric formulation to treat schistosomiasis as a member of the Pediatric Praziquantel Consortium… Continue reading EMA Recommends Arpraziquantel for Treatment of Schistosomiasis in Preschool-Aged Children
Category: Newswire
Sycuan entrega $180,000 a 25 organizaciones de beneficencia durante la ceremonia de entrega de regalos navideños de 2023
SAN DIEGO, 17 de diciembre de 2023 /PRNewswire-HISPANIC PR WIRE/ — El jueves 7 de diciembre, Sycuan Casino Resort entregó $180,000 a 25 organizaciones de beneficencia diversas durante su ceremonia de entrega de regalos navideños de 2023. Cada diciembre, los miembros del Consejo Tribal de Sycuan y la gerencia de Sycuan seleccionan individualmente a una… Continue reading Sycuan entrega $180,000 a 25 organizaciones de beneficencia durante la ceremonia de entrega de regalos navideños de 2023
Patriot Drills 56.6 m at 1.37% Li2O in Step-Out Hole and Completes Final Hole of 2023 Program at the CV5 Pegmatite, Quebec, Canada
VANCOUVER, BC, Dec. 17, 2023 /PRNewswire/ – December 18, 2023 – SYDNEY, Australia Highlights Continue Reading Figure 4: Remain to be drill tested corridor between the CV5 & CV13 spodumene pegmatites. (CNW Group/Patriot Battery Metals Inc) Figure 5: Drill holes completed through 2023 at CV13 Spodumene Pegmatite. (CNW Group/Patriot Battery Metals Inc) Table 2: Core… Continue reading Patriot Drills 56.6 m at 1.37% Li2O in Step-Out Hole and Completes Final Hole of 2023 Program at the CV5 Pegmatite, Quebec, Canada
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN
NEW YORK, Dec. 17, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC. (NASDAQ: SLRN) between May 4, 2023 and September 11, 2023, both dates inclusive (the “Class Period”), of the important January 16, 2024 lead plaintiff deadline. SO WHAT: If you purchased ACELYRIN securities… Continue reading ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN
Illumina Announces Decision to Divest GRAIL
SAN DIEGO, Dec. 17, 2023 /PRNewswire/ — Today, Illumina, Inc. (NASDAQ: ILMN) announced that the company will divest GRAIL. The divestiture will be executed through a third-party sale or capital markets transaction, consistent with the European Commission’s divestiture order, with the goal of finalizing the terms by the end of the second quarter of 2024.… Continue reading Illumina Announces Decision to Divest GRAIL
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OTLK
NEW YORK, Dec. 17, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outlook Therapeutics, Inc. (NASDAQ: OTLK) between December 29, 2022 and August 29, 2023, both dates inclusive (the “Class Period”), of the important January 2, 2024 lead plaintiff deadline. SO WHAT: If you purchased Outlook securities… Continue reading ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OTLK
Florida Law Firm Takes a Stand in Product Liability Cases Spanning Various Sectors
FORT LAUDERDALE, Fla., Dec. 17, 2023 /PRNewswire/ — The Law Offices of Jason Turchin announces its robust involvement in handling a wide array of product liability cases, advocating for victims of defective and dangerous products in various categories. The firm’s dedicated webpage, National Product Liability Lawyers, serves as a comprehensive resource for individuals seeking legal… Continue reading Florida Law Firm Takes a Stand in Product Liability Cases Spanning Various Sectors
First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM
SHANGHAI, Dec. 17, 2023 /PRNewswire/ — YolTech Therapeutics today announced that the first patient has been dosed with YOLT-201, the company’s first in vivo genome editing candidate being developed as a single dose, potentially curative therapy for hereditary transthyretin amyloidosis with cardiomyopathy (ATTR-CM). The study by YolTech is a single-arm, open-label, dose-escalation clinical trial (Clinicaltrials.gov:… Continue reading First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM
FTCH DEADLINE TUESDAY: ROSEN, A RANKED AND LEADING FIRM, Encourages Farfetch Limited Investors With Losses in Excess of $100K to Secure Counsel Before Important December 19 Deadline in Securities Class Action – FTCH
NEW YORK, Dec. 17, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Farfetch Limited (NYSE: FTCH) between March 9, 2023 and August 17, 2023, both dates inclusive (the “Class Period”), of the important December 19, 2023 lead plaintiff deadline. SO WHAT: If you purchased Farfetch Limited… Continue reading FTCH DEADLINE TUESDAY: ROSEN, A RANKED AND LEADING FIRM, Encourages Farfetch Limited Investors With Losses in Excess of $100K to Secure Counsel Before Important December 19 Deadline in Securities Class Action – FTCH
Snow Hill Success!–Quark Expeditions Goes Beyond in Antarctica
Quark Expeditions’ technologically-advanced expedition ship, Ultramarine, and its team delivered these successful Snow Hill voyages in November and December, while also hosting a special onboard ceremony at the edge of Antarctica’s Weddell Sea: the official announcement of Dr Sian Proctor as Ultramarine‘s godmother. Joined by the company’s legendary Expedition Leader, Shane Evoy, together with ship’s Captain Jurak… Continue reading Snow Hill Success!–Quark Expeditions Goes Beyond in Antarctica